32.77
-0.37 (-1.12%)
| Previous Close | 33.14 |
| Open | 33.08 |
| Volume | 55,946 |
| Avg. Volume (3M) | 293,952 |
| Market Cap | 301,091,904 |
| Price / Earnings (Forward) | 217.39 |
| Price / Sales | 2.78 |
| Price / Book | 40.66 |
| 52 Weeks Range | |
| Earnings Date | 11 Nov 2026 |
| Profit Margin | -12.48% |
| Operating Margin (TTM) | -8.88% |
| Diluted EPS (TTM) | -1.34 |
| Quarterly Revenue Growth (YOY) | 26.40% |
| Total Debt/Equity (MRQ) | 121.96% |
| Current Ratio (MRQ) | 2.77 |
| Operating Cash Flow (TTM) | -1.80 M |
| Levered Free Cash Flow (TTM) | 1.01 M |
| Return on Assets (TTM) | -4.72% |
| Return on Equity (TTM) | -29.22% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Instruments & Supplies (US) | Mixed | Mixed |
| Medical Instruments & Supplies (Global) | Mixed | Mixed | |
| Stock | Sanara MedTech Inc. | Mixed | Bearish |
AIStockmoo Score
| Analyst Consensus | NA |
| Insider Activity | NA |
| Price Volatility | -1.5 |
| Technical Moving Averages | -2.5 |
| Technical Oscillators | -0.5 |
| Relative Valuation | NA |
| Financial Health | NA |
| AI Insight | NA |
| Weighted Average | -1.50 |
Select this tab to load the latest available analysis.
|
Sanara MedTech Inc is a medical technology company focused on developing and commercializing technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical market. It markets and sells soft tissue repair and bone fusion products for use in operating rooms and sterile environments. Its soft tissue repair products include CellerateRX Surgical Powder, a hydrolyzed collagen used in management of surgical wounds, and BIASURGE Surgical Solution, a sterile no-rinse solution for wound irrigation, while its bone fusion products include BiFORM Bioactive Moldable Matrix, an osteoconductive implant that supports bone growth, and ALLOCYTE Plus Viable Bone Matrix, a human allograft cellular bone matrix containing bone-derived progenitor cells and conformable bone fibers. |
|
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Investment Style | Small Growth |
| % Held by Insiders | 66.47% |
| % Held by Institutions | 10.43% |
No data within this time range.
No data within this time range.
AI Technical Analysis
Open the Technical tab to generate the latest analysis.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |